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Abstract
Background: Dark chocolate (DC) is abundant in flavanols which have been reported to increase the bioavailability
and bioactivity of nitric oxide (NO). Increasing NO bioavailability has often demonstrated reduced oxygen cost and
performance enhancement during submaximal exercise.
Methods: Nine moderately-trained male participants volunteered to undertake baseline (BL) measurements that
comprised a cycle :VO2max test followed by cycling at 80 % of their established gas exchange threshold (GET) for
20-min and then immediately followed by a two-minute time-trial (TT). Using a randomised crossover design
participants performed two further trials, two weeks apart, with either 40 g of DC or white chocolate (WC) being
consumed daily. Oxygen consumption, RER, heart rate and blood lactate (BLa) were measured during each trial.
Results: DC consumption increased GET and TT performance compared to both BL and WC (P < 0.05). DC
consumption increased :VO2max by 6 % compared to BL (P < 0.05), but did not reach statistical significance
compared to WC. There were no differences in the moderate-intensity cycling for :VO2, RER, BLa and heart rate
between conditions, although, :VO2 and RER exhibited consistently lower trends following DC consumption
compared to BL and WC, these did not reach statistical significance.
Conclusion: Chronic supplementation with DC resulted in a higher GET and enhanced TT performance.
Consequently, ingestion of DC reduced the oxygen cost of moderate intensity exercise and may be an effective
ergogenic aid for short-duration moderate intensity exercise.
Keywords: Gas exchange threshold, Flavanols, High-intensity, Time trial
Background
Dietary supplementation with sodium nitrate or nitrate
rich beetroot juice has become increasingly popular and
has consistently been shown to reduce oxygen demands
during submaximal exercise and resting blood pressure
(BP) [1, 2]. The physiological mechanisms underpinning
these enhancements in contractile efficiency have been
attributed to the breakdown of nitrate to the substantial
elevation of circulating nitrite, which is subsequently
converted into the bioactive nitric oxide (NO), that may
potentially increase vasodilation, glucose uptake and
regulate muscular contraction [3–7].
Although supplementation with beetroot juice has be-
come popular as an ergogenic aid, it is renowned for its
poor palatability and lack of energy provision. Recent
studies reported similar vascular improvements in NO
levels from consumption of dark chocolate (DC) [8, 9].
This is of great interest given the popularity of DC often
associated with food categories of high palatability and
indulgence. Dark chocolate mechanistically unique to
other dietary nitrate supplements augments NO produc-
tion through endothelium-dependent influences [10, 11].
The abundant amount of (-)-epicatechin found within DC
signals release of vasoactive components from the endo-
thelial cells increasing the bioavailability of NO [12, 13].
The increased bioavailability and activity of NO have been
demonstrated to statisitically increase flow-mediated dila-
tion in healthy patients (46 g/day for fifteen days) [14],
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hypertensive patients (100 g/day for fifteen days) [15], pre-
hypertensive patients (30 g/day for fifteen days) [13], and
stage 1 hypertension patients (6.3 g/day for eighteen
weeks) [16].
To date, the research surrounding DC has predomin-
antly focused on its beneficial influences on cardiovascu-
lar health and has received limited focus towards the
effects on exercise performance. Berry et al. [17] demon-
strated attenuation in exercise-induced blood pressure
through consumption of flavanol rich cocoa within over-
weight participants, demonstrating DC may decrease
cardiovascular risk and enhance the cardiovascular bene-
fits of moderate intensity exercise in at-risk individuals.
Allgrove et al. [18] reported consumption of DC (40 g)
for two weeks was associated with reduced oxidative-
stress markers following prolonged exhaustive exercise
and increased mobilization of free fatty acids after exer-
cise. Allgrove et al. [18] and Berry et al. [17] also sug-
gested that increased NO levels resulted in lower RER
and improvements in moderate intensity.
To date, no studies have addressed the link between
the reported increases in NO and nitrate levels resulting
from consumption of DC and for its potential to lower
oxygen demand during moderate intensity exercise and
enhance performance during high-intensity exercise.
Therefore, the purpose of this study was to examine
whether commercially available DC, will elicit an im-
provement in gas exchange threshold (GET), lower oxy-
gen consumption during moderate intensity cycling
(80 % GET) and improve performance in a time trial in
comparison to white chocolate.
Materials and methods
Participants
Following Institutional approval nine moderately trained
males (mean ± SD; Age 21 ± 1 years, body mass 76.0 ±
9.3 kg, stature 177 ± 9.4 cm and :VO2max 41.89 ± 5.4 ml/
kg/min) volunteered to participate and provided written
informed consent to participate in the study. All proce-
dures and conduct met with Declaration of Helsinki.
Dietary control
Participants were instructed to maintain their normal
diet and refrain from alcohol, vitamin supplements, anti-
inflammatory products and from consumption of milk
two hours before and after consumption of either sup-
plementation, to increase absorption over the period of
intervention. Participants were also provided with a
dietary list of prohibitory foods high in nitrate with an
appropriate low nitrate replacement. To prevent an in-
crease surplus in daily caloric energy intake, participants
replaced a snack meal or dessert with similar caloric
values for DC/WC and were instructed not reduce their
fruit and vegetable consumption. The DC and WC were
best matched for calorific content (total energy provision
over 14 days was 12887 kJ & 12945 kJ for DC and WC
respectively) and no other supplementation was allowed
throughout the intervention including consuming any
other chocolate. In the 24 h preceding the first exercise
test, participants were asked to record their dietary in-
take, detailing all foods consumed, and this diet was repli-
cated in the 24 h preceding subsequent tests. Participants
were instructed to avoid any strenuous activity in the 24 h
preceding each testing session, to refrain from caffeine for
six hours and from alcohol for 24 h before each testing
session. During the 2-week washout period between inter-
ventions, participants were not required to adhere to any
specific dietary regime, but to avoid chocolate.
Experimental design
To examine whether dark chocolate consumption affects
:VO2max (ml/kg/min), blood pressure (BP) (mmHg), oxy-
gen cost (ml/kg/min), and lactate levels (mmol/L) during
a 20-min cycle test at 80 % GET and all out sprint per-
formance (m), a randomised crossover design was used
with participants blinded to the aims of the study. Base-
line tests (BL) were used to accustom participants to
testing protocols (Fig. 1), establish GET for the entirety
of the protocol, and for participants to be randomly
assigned to either a daily intake of DC (40 g, DOVE®,
Dark Chocolate, Mars, Incorporated, Hackettstown, NJ)
or white chocolate (WC) (40 g of Milkybar®) for fourteen
days, followed by a seven day wash out period, then
switched to the alternative treatment. The commercially
available dark chocolate was chosen as it was previously
reported to be rich in (-)-epicatechin [14]. Fourteen days
of supplementation was used as Sudarma et al. [13] re-
ported increases in NO following DC consumption of
this quantity an duration.
Equipment and procedures
All three laboratory visits were performed at the same
time of day on different days and performed in a stan-
dardised order (Fig. 1).
Resting measures
Stature was measured to the nearest 0.1 cm using stadi-
ometer and body mass was measured to the nearest
0.05 kg using an electronic scales (Seca, Vogel & Halke,
Germany). Participants were rested supine for five mi-
nutes before BP measurements were taken using a
Maruman digital automatic BP monitor (Maruman Co.
Ltd., Tokyo, Japan). On each occasion, three measure-
ments were taken, with a 60s rest between each meas-
urement and the mean value reported.
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Incremental test :VO2maxð Þ
All tests were performed on an electromagnetically
braked cycle ergometer (Velotron Cycles, Racermate
Inc., Seattle, Washington, USA). A ramp incremental
test was used in accordance with Bailey et al. [1] proce-
dures with the primary purpose to establish each partici-
pant GET. Participants cycled at a self-selected pedal
rate between 70–90 rpm for 3-min ‘unloaded’ (0 W)
warm up, after which the work rate was increased at a
rate of 30 W/min until volitional exhaustion. Pedal rate,
saddle height, and handle bar height configuration were
recorded and reproduced in subsequent tests. Pul-
monary gas exchange was continually collected
throughout the incremental test (Oxycon Pro, VIASYS
GmbH, Eric Jaeger, Hoechberg, Germany) and was av-
eraged to fifteen seconds collection periods. :VO2max
Fig. 1 Schematic illustration of the exercise test protocol
Fig. 2 Maximal oxygen consumption (ml/kg/min) of participants at
BL and after consumption of DC (n = 9) and WC (n = 9). *Denotes
significant difference between DC (P ≤ 0.05)
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was recorded as the highest value achieved over a 15-
s collection period.
Moderate intensity cycle
Participants rested for 30 min after completing the in-
cremental test, before commencing moderate cycling.
To ensure consistency across conditions, the GET and
corresponding power output for all three conditions (BL,
DC, WC) was calculated from the BL :VO2max test. The
GET from the baseline test was determined as the work
rate corresponding at the precise cross over, at which
VE/ :VO2 continually exceed VE/VCO2. A power output
corresponding to 80 % of GET was used as the moderate
cycling intensity for twenty minutes at a self-selected
pedal cadence. Heart rate and pulmonary gas exchange
were collected continually throughout the 20-min cycle
and averaged to five-minute intervals. Capillary blood
was collected from the index fingertip every five minutes
and analysed for concentrations of lactate (Arkray Fac-
tory Inc, 1480 Oaza Kouji umeda, kounan-cho kouka
gmn, Shiga, Japan).
Distance time trial
On completion of the moderate intensity cycling, partici-
pants were instructed to cycle maximally for two mi-
nutes and the total distance (m) achieved was recorded.
Statistical analysis
Data was analysed for normality using Shapiro Wilks. A
two factor within-subject repeated measures ANOVA was
used to analyse the differences over the 20 min of moder-
ate intensity exercise (oxygen consumption, RER, lactate
levels and heart rate) with Newman Keuls post-hoc tests
used when differences were found. A paired t-test was
used to measure the difference between all other
dependent variables. Data was presented as mean ± stand-
ard deviation (SD), unless otherwise stated. Statistical sig-
nificance was accepted when P ≤ 0.05.
Results
Maximal oxygen consumption
Maximal oxygen consumption was 6 % higher following
DC consumption (44.52 ± 6.43 ml/kg/min) compared to
BL (41.89 ± 5.4 ml/kg/min, P = 0.037, 95 % CI = 5.05–0.21,
Fig. 2) and also 6 % greater than that of WC (41.84 ±
5.6 ml/kg/min, P = 0.071, Fig. 2), but this did not reach
statistical significance. There was no difference between
maximal oxygen consumption following WC consump-
tion compared to BL.
Gas exchange threshold
GET for both conditions was estimated from the :V
O2max test undertaken for that condition post exercise.
DC consumption (197 ± 43 W) significantly increased
gas exchange threshold by 21 % compared to BL (163 ±
37 W, P = 0.007, 95 % CI = 54.73–11.93, Fig. 3) and was
11 % higher compared to WC (177 ± 28 W, P = 0.05,
95 % CI = 0.29–39.97, Fig. 3). Gas exchange threshold
was not different following consumption of WC com-
pared to BL (P = 0.225, Fig. 3).
Fig. 3 Gas exchange threshold (W) at BL and after consumption of
DC (n = 9) and WC (n = 9). *Denotes significant difference between
DC and BL (P < 0.05). # Denotes a significant difference between DC
and WC (P < 0.05)
Fig. 4 Oxygen consumption (ml/kg/min) of participants over twenty minutes during the moderate intensity cycle at BL and after consumption of
DC (n = 9) and WC (n = 9)
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Oxygen consumption during the moderate intensity cycle
All 20-min sub-maximal tests were undertaken at an in-
tensity corresponding to 80 % of GET obtained in the BL
trial. Oxygen consumption during the moderate intensity
cycle was not different between conditions (P = 0.269,
Eta = 0.151, Fig. 4). However, there were within-trial
differences for all conditions that increased across
time between 0–20 min (P < 0.001, Fig. 4).
Respiratory exchange ratio during the moderate intensity
cycle
Respiratory exchange ratio was not different between con-
ditions (P = 0.488, Eta = 0.86 Fig. 5). However, there were
within-trial differences for all conditions that increased
across time between 0 to 20 min (P < 0.001, Fig. 5).
Blood pressure
Systolic BP was not different between conditions (P = 0.101,
Fig. 6), DC resulted in a 6 % decrease in systolic blood com-
pared to WC and 5 % decrease compared to BL; although
these difference did not reach statistical significance. Dia-
stolic BP was not different between conditions (P = 0.531,
Fig. 6), although DC resulted in a 6 % increase in diastolic
BP compared to WC and BL, but this did not reach statis-
tical significance.
Blood lactate during the moderate intensity cycle
Blood lactate was not different between conditions (P =
0.456, Eta = 0.093, Fig. 7). However, there were within-trial
differences for all conditions across time that had no con-
sistent identifiable trends (P = 0.479, Eta = 0.096, Fig. 7).
Heart rate during the moderate intensity cycle
Heart rate was not different between conditions (P = 0.245,
Eta = 0.161, Fig. 8). However, there were within-trial differ-
ences for all conditions that increased across time between
0–20 min (P = 0.001, Eta = 0.62, Fig. 8).
Distance time trial
DC consumption resulted in a greater total distance cov-
ered of 17 % (1606 ± 158 m, P = 0.001, 95 % CI =
312.76–165.01, Fig. 9) compared to BL (1367 ± 171 m)
and a 13 % increase compared to WC (1419 ± 248 m,
P = 0.003, 95 % CI = 291.21–82.11, Fig. 9). Total dis-
tance covered during the time trial was not different
Fig. 5 Respiratory exchange ratio of participants over twenty minutes during the moderate intensity cycle at BL and after consumption of DC
(n = 9) and WC (n = 9)
Fig. 6 Systolic and diastolic blood pressure (mmHg) at BL and after consumption of DC (n = 9) and WC (n = 9)
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following consumption of WC compared to BL (P = 0.319,
Fig. 9)
Discussion
To date, this is the first study to investigate the effects of
Dark Chocolate (DC) on :VO2max , GET, oxygen demand
during moderate intensity cycling, and a maximal per-
formance time trial. The main finding was that regular
consumption of DC daily (40 g) for fourteen days re-
sulted in a significantly higher GET (21 and 11 %) and
the total distance covered (17 and 13 %) during a max-
imal two minute maximal sprint compared to both base-
line and WC conditions. Consumption of DC increased
:VO2max compared to baseline (P = 0.037). However, WC
also marginally increased :VO2max compared to baseline
and this increase reduced the difference between WC and
DC resulting in statistical significance not attaining the
determined critical threshold (P = 0.071). There were no
differences in the moderate intensity cycling in :VO2
RER, BLa, and heart rate between conditions. Further-
more there was no difference on systolic BP and diastolic
BP between conditions.
While the specific mechanisms underlying this in-
crease in GET and 2-min maximal sprint remains elusive
it can be proposed that flavanol a subclass of DC is a
particular compound of interest and may be responsible
for eliciting the observed effects [3, 5, 19–21]. Dark
Chocolate (DC), unique to other dietary nitrate supple-
ments is hypothesised to mediate NO production
through endothelium-dependent effects; related to flava-
nols’ ability to supress vascular arginase enzyme activity,
thus increasing the production of NO [4, 13, 22, 23].
Dark chocolate’s vasodilatative properties can be attrib-
uted to the increase in levels of (-)-epicatechin, which
are further converted to 0-methylated metabolites that
are potent inhibitors of NADPH oxidase. This suppreses
oxygen free radical generation which increases the bio-
availability of NO [10, 11]. Fisher et al. [24] and Sudarma
et al. [13] both reported increased (-)-epicatechin within
the blood following DC consumption; however both ob-
tained DC which was manufactured to be precisely rich
in flavanols by limiting the degradation, alkylation, and
roasting of the cocoa seeds. The present study used
Dove DC as Engler et al. [14] reported high associated
polyphenol and (-)-epicatechin values; although, it was
not stated whether the DC was specifically manufac-
tured or was identical to the commercially available
brand, as this may well contribute to a potentially lower
Fig. 7 Blood lactate (mmol/L) of participants during the twenty minute moderate intensity cycle taken at 5 min, 10 min, 15 min and 20 min at BL
and after consumption of DC and WC
Fig. 8 Heart rate (bpm) of participants during the twenty minute moderate intensity cycle taken at 5 min, 10 min, 15 min and 20 min at BL and
after consumption of DC and WC
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flavanol and (-)-epicatechin concentration, thus may have
potentially attenuated observed effects within this study.
A caveat of the present study was that flavanol and NO
were not directly measured thus the causation of the ob-
served effects is speculated around flavanol and NO.
After 14 days consumption of DC, GET significantly
increased by 11 % compared to WC and increased by
21 % compared to baseline. Similarly, :VO2 during mod-
erate intensity cycling was consistently lower throughout
the entire duration of cycling following consumption of
DC (Fig. 2) compared to baseline and WC. However, :V
O2 did not reach the threshold associated with statistical
significance. The increases in GET complements findings
by previous research using dietary nitrate supplementa-
tion which have been attributed to increased NO, which
has been extensively shown to increase following regular
consumption of DC [1, 2, 6].
Respiratory exchange ratio (RER) did not significantly
differ between conditions (Fig. 4). These results conflict
with Allgrove et al. [18], which reported lower RER
values during exercise at 60 % :VO2max , also indicating
increased fat oxidation. Furthermore, consumption of
DC was also reported to increase free fatty acid mobil-
isation during prolonged cycling following DC consump-
tion, which could be viewed beneficial to those with
goals tailored towards weight loss and athletes in need
of conserving carbohydrate stores. However, the dur-
ation of the tests in this study were probably too short
to elicit a decrease in RER. Moreover, DC does contain
trace elements of caffeine and theobromine, which can
independently increase free fatty acid mobilisation; al-
though, the dose found is relatively small to make a sub-
stantial alteration in metabolism [25].
Unlike previously reported studies by Faridi et al. [26]
and Sudarma et al. [13] systolic and diastolic BP was not
seen to be significantly different between DC and WC.
Systolic BP was attenuated by 6 % following the inges-
tion of DC to a healthier range (124 ± 7 mmHg), and
diastolic BP increased by 6 % following ingestion of DC
(74 ± 9 mmHg), which was also associated with healthier
ranges. However, Faridi et al. [26] and Sudarma et al.
[13] the participants in the present study were all
healthy and had no irregular BP, possibly hindering the
chance of finding a significant difference.
Conclusion
This is the first study that has investigated the effects of
DC consumption on GET, oxygen demands during a
twenty-minute moderate cycle, :VO2max and perform-
ance of a two-minute maximal sprint. The primary out-
come observed was DC consumption increased the work
rate achieved at GET by 11 % compared to WC and
21 % compared to baseline (P < 0.05). Time trial dis-
tances following DC consumption were higher com-
pared to baseline and WC (P < 0.05). Maximal oxygen
consumption also increased following DC compared to
baseline (P < 0.05), but was not significantly different to
WC. However, despite oxygen consumption and RER be-
ing consistently lower throughout the twenty minutes of
moderate intensity cycling, no significant difference was
observed. Consequently, it can be concluded that inges-
tion of DC for 14 days reduced the oxygen cost of moder-
ate intensity exercise and may be an effective ergogenic
aid for short-duration moderate intensity exercise. How-
ever, future double-blinded studies will need to confirm
this effect.
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